“I was inspired by one of my colleagues at university who was part of the program last year and now promotes it in India. I was lucky enough to be selected to come here to Canada for research into leukemia in children.”
Manish is about to begin his final year of studies for a Bachelor of Technology degree with a major in Biotechnology and a minor in Computer Science at the Indian Institute of Technology Guwahati.
Severe brain damage induced by a stroke produces a reduction of immune functioning, which can result in fatal infections threatening the survival of patients after a stroke. Given that 20-25% of patients fall victim to infection post-stroke, this research is highly significant.
Diego comes from Guadalajara, Mexico’s Monterrey Institute of Technology and Higher Education where he is working towards his undergraduate degree in Biotechnology. It was his initial intrigue with DNA that drove him to this field of study, but now the possibility that his research will have real world impact has pushed him to pursue his masters.
However, the cost of research and development of natural health products is often impossibly steep as the products must be rigorously tested and proven before they can be placed on store shelves.
With this challenge ahead of them, the Alberta “phyto-pharmaceutical” biotech company, SinoVeda, turned to Mitacs-Accelerate to assist in the advanced testing of its latest natural calcium supplement which is currently undergoing clinical trials.
The company is developing a novel cancer vaccine based on a specific antigen and needed the research expertise to help them understand, at a molecular level, how that antigen is expressed in different types of cancer. They turned to Dalhousie postdoctoral fellow Olga Hrytsenko for insight. Olga’s 17 years of molecular biology experience is the “perfect fit” for the project says Marianne Stanford, Director of Research, at Immunovaccine.
As a PhD student in Western University's department of Physiology and Pharmacology, Gurjeev’s research focuses on uncovering molecular mechanisms that predispose low birth weight babies to increased risk of developing cardiovascular diseases in adult life.
Because of this research, BC Children’s Hospital can how examine all new cases of pediatric brain tumors throughout the entirety of Western Canada with precision and accuracy – thus reducing the (often excessive) intensity of treatment for children with cancer while still effectively treating the disease. Below is an exclusive interview with Ms.
The research led to the completion of a motorized incubator device that now enables researchers to observe live cells for days at a time as they are stretched under the microscope. His work may help to cure a devastating skin blistering disease called epidermolysis bullosa simplex. Below is an exclusive interview with Mr.
After having come to Canada for a summer English language camp in 2010, Barbara Paes of Universidade de Brasília was always looking for opportunities to return to Canada. So when her friend told her about the Mitacs Globalink program one week before the application deadline, she hurried to apply before it was too late. Now studying at the University of British Columbia’s Brain Research Centre, Barbara has fallen in love with Canada all over again.